Evidence map›Paper›PMID 39068473›Full record

ArticleEuropean journal of medical research2024

Decoding single-cell molecular mechanisms in astrocyte-to-iN reprogramming via Ngn2- and Pax6-mediated direct lineage switching.

Rongxing Qin, Yingdan Zhang, Yue Yang, Jiafeng Chen, Lijuan Huang, Wei Xu, Qingchun Qin, Xiaojun Liang, Xinyu Lai, Xiaoying Huang and 2 more

Abstract read
In one paragraph

Article in European journal of medical research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Rongxing Qin *Department of Neurology, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China.
Yingdan Zhang *Department of Neurology, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China.
Yue YangDepartment of Neurology, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China.
Jiafeng ChenDepartment of Neurology, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China.
Lijuan HuangDepartment of Neurology, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China.
Wei XuDepartment of Neurology, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China.
Qingchun QinDepartment of Neurology, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China.
Xiaojun LiangDepartment of Neurology, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China.
Xinyu LaiDepartment of Neurology, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China.
Xiaoying HuangDepartment of Neurology, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China.
Minshan XieDepartment of Neurology, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China.
Li ChenDepartment of Neurology, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China. chenli@gxmu.edu.cn.

Funding

National Natural Science Foundation of China 82271371the Clinical Research "Climbing" Program of the First Affiliated Hospital of Guangxi Medical University YYZS2021002the Guangxi Medical and Health Appropriate Technology Development and Application Project S2021107the Innovation Project of Guangxi Graduate Education YCSW2023242
6 · The paper itself

Abstract

backgroundThe limited regenerative capacity of damaged neurons in adult mammals severely restricts neural repair. Although stem cell transplantation is promising, its clinical application remains challenging. Direct reprogramming, which utilizes cell plasticity to regenerate neurons, is an emerging alternative approach.

methodsWe utilized primary postnatal cortical astrocytes for reprogramming induced neurons (iNs) through the viral-mediated overexpression of the transcription factors Ngn2 and Pax6 (NP). Fluorescence-activated cell sorting (FACS) was used to enrich successfully transfected cells, followed by single-cell RNA sequencing (scRNA-seq) using the 10 × Genomics platform for comprehensive transcriptomic analysis.

resultsThe scRNA-seq revealed that NP overexpression led to the differentiation of astrocytes into iNs, with percentages of 36% and 39.3% on days 4 and 7 posttransduction, respectively. CytoTRACE predicted the developmental sequence, identifying astrocytes as the reprogramming starting point. Trajectory analysis depicted the dynamic changes in gene expression during the astrocyte-to-iN transition.

conclusionsThis study elucidates the molecular dynamics underlying astrocyte reprogramming into iNs, revealing key genes and pathways involved in this process. Our research contributes novel insights into the molecular mechanisms of NP-mediated reprogramming, suggesting avenues for optimizing the efficiency of the reprogramming process.

Indexed as

AstrocytesBasic Helix-Loop-Helix ProteinsCellular ReprogrammingNerve Tissue ProteinsPAX6 Transcription FactorSingle-Cell AnalysisAnimalsCell DifferentiationCell LineageCells, CulturedMiceNeuronsBasic Helix-Loop-Helix ProteinsNerve Tissue ProteinsNeurog2 protein, mousePax6 protein, mousePAX6 Transcription Factor

Identifiers

PMID39068473
PMCPMC11282629

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.